L3MBTL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.286400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.203200E-01
Normal-vs-Stage2
4.436800E-01
Normal-vs-Stage3
2.318400E-01
Normal-vs-Stage4
5.445600E-01
Stage1-vs-Stage2
1.985640E-01
Stage1-vs-Stage3
8.026200E-01
Stage1-vs-Stage4
2.129000E-01
Stage2-vs-Stage3
4.364600E-01
Stage2-vs-Stage4
4.294400E-01
Stage3-vs-Stage4
3.500400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.233600E-01
Normal-vs-AfricanAmerican
2.644800E-01
Normal-vs-Asian
3.745800E-01
Caucasian-vs-AfricanAmerican
7.738600E-01
Caucasian-vs-Asian
4.820000E-01
AfricanAmerican-vs-Asian
4.887000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.300200E-01
Normal-vs-Female
4.310200E-01
Male-vs-Female
9.812800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.309400E-01
Normal-vs-Age(41-60Yrs)
4.898400E-01
Normal-vs-Age(61-80Yrs)
4.111000E-01
Normal-vs-Age(81-100Yrs)
3.781200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.703400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.917400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.099200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.287810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.728230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.690600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.052800E-01
Normal-vs-Daily Drinker
3.409200E-01
Normal-vs-Weekly Drinker
3.870600E-01
Normal-vs-Occasional Drinker
1.468220E-01
Normal-vs-Social Drinker
4.525400E-01
Non Drinker-vs-Daily Drinker
3.177800E-01
Non Drinker-vs-Weekly Drinker
8.083800E-01
Non Drinker-vs-Occasional Drinker
6.693800E-01
Non Drinker-vs-Social Drinker
6.342400E-01
Daily Drinker-vs-Weekly Drinker
5.002400E-01
Daily Drinker-vs-Occasional Drinker
2.175400E-01
Daily Drinker-vs-Social Drinker
1.796190E-01
Weekly Drinker-vs-Occasional Drinker
5.722400E-01
Weekly Drinker-vs-Social Drinker
5.141000E-01
Occasional Drinker-vs-Social Drinker
9.714200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.855400E-01
Normal-vs-Grade 2
4.215500E-03
Normal-vs-Grade 3
2.063800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.727700E-02
Grade 1-vs-Grade 3
9.329800E-02
Grade 1-vs-Grade 4
1.855400E-01
Grade 2-vs-Grade 3
8.572000E-01
Grade 2-vs-Grade 4
4.215500E-03
Grade 3-vs-Grade 4
2.063800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.298600E-01
Normal-vs-NonDiabetic
3.990200E-01
Diabetic-vs-NonDiabetic
5.634400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.117600E-01
Normal-vs-NoPancreatitis
4.100200E-01
Pancreatitis-vs-NoPancreatitis
9.862600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.126800E-01
Normal-vs-N1
4.476800E-01
N0-vs-N1
4.904400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.348600E-01
Normal-vs-TP53-NonMutant
3.416600E-01
TP53-Mutant-vs-TP53-NonMutant
1.290560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
